More than health risks play a role in compliance with coronavirus measures The risk of COVID-19 is not the only factor that determines compliance with the coronavirus measures; other risks also play a role.
No evidence of more serious illness from COVID-19 among Q fever patients There are no indications that people who previously had Q fever had a more serious course of illness from the coronavirus SARS-CoV-2. This is evident from RIVM research.
Specific group of patients with impaired immunity invited in October for third COVID-19 vaccination From 6 October on, a specific group of people with severely impaired immunity (immunocompromised patients) will receive their invitation for a third vaccination against COVID-19.
Sustainable procurement benefits people and the environment RIVM has developed a method to calculate the effects of Sustainable Procurement and applied the method to eight product groups: energy, gas, solar panels, company cars, business trips, workwea
First products Dutch Public Health Foresight study available in English In 2017, RIVM launched a Trend Scenario, as well as three thematic reports about the future demand for health care, technology and wider determinants of health.
Smart lotteries promote physical activity Commitment lotteries can support overweight adults in their goal to exercise on a regular basis.That is the conclusion of a scientific study by Tilburg University, High Five Health Promotion and RI
Climate Resilient Water Safety Plans Workshop Mozambique RIVM and the Institute for Water Education (IHE) Delft facilitated a workshop on Climate Resilient Water Safety Plans (CR-WSP) on January 22 - 23 2018, in Maputo, Mozambique.
Chance of ESBL contamination via livestock farming is small ESBL is an enzyme, produced by certain bacteria, which makes these bacteria resistant to antibiotics.
RIVM publications score above average worldwide A new bibliometric analysis method of the University of Leiden shows that the publications of the Strategic Programme of RIVM (SPR) score well worldwide.
New test has no added value in Lyme disease of the central nervous system Active Lyme disease of the central nervous system cannot be detected with an ELISpot test.